Though a few recent investigations suggest that EZH2 could play a pro-tumorigenic role in gliomas, specifically in DMG, the exact contribution of EZH2 in this disease is lacking partly due to the absence of appropriate in vivo mouse models. This evidence concerns the gene EZH2 and glioma.